UBS initiated coverage of Sabra Health Care (SBRA) with a Neutral rating and $20 price target The company should benefit from demographic tailwinds, a favorable skilled nursing facility backdrop, and expanding rent coverage ratios, the analyst tells investors in a research note. However, the firm believes this is already priced into the shares.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SBRA:
- Hold Rating for Sabra Healthcare REIT Amidst Balanced Valuation and Strategic Challenges
- Sabra Health Care REIT Reports Strong Q3 2025 Results
- Sabra Healthcare REIT’s Optimistic Earnings Call Analysis
- Sabra Healthcare REIT: Balancing Strong FAD Performance with Capital Cost Challenges
- Sabra Healthcare REIT Reports Q3 Results and Upgraded Rating